Article
Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.
Journal of pediatric hematology/oncology - 1 May 2008
Shimasaki Noriko, Mori Tetsuya, Torii Chiharu, Sato Reiko, Shimada Hiroyuki, Tanigawara Yusuke, Kosaki Kenjiro, Takahashi Takao
Abstract excerpt
We investigated preliminarily whether methylenetetrahydrofolate reductase (MTHFR) 677C/T or reduced folate carrier 1 (RFC1) 80G/A polymorphisms were associated with toxicities during maintenance chemotherapy with mercaptopurine (6MP) and methotrexate (MTX) in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. The clinical records of 20 children (2 to 15-y old) who had received maintenance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
